tions for scientific investigation. Science cannot set priorities for action. It may provide society with the necessary data; it may demonstrate need and the means to meet that need; and it may help us to obtain a better idea of society's perception of that need. Ultimately, however, it does not remove the responsibility of society to make the final decision about what is worthwhile, and what should therefore be done.
John Swales, MD Professor of Medicine University of Leicester
Leicester UK
The impact of health economics on health policy and pradice
Recently two major events took place which were instructive in assessing the role of health services research in general and that of health economics in particular.
The first was the third European Conference on Health Economics in Stockholm and the second was the International Conference on the Scientific Basis of Health Services in London. Interestingly, quite a bit of attention at the Stockholm conference was devoted to multidisciplinary research rather than strict economics. Other disciplines clearly contribute to the methods and practice of an important area within health economics, namely economic evaluation. Furthermore, in their keynote address at the end of the Stockholm meeting, Greg Stoddart and Morris Barer from Canada suggested that health economists should work more closely with other disciplines not only in answering the question of how to cure sick people in a cost-effective way, but also to broaden the question to identifying both the determinants of illness and the policies which influence those determinants and thus produce the greatest health benefit at the population level. Insight into the interdependency between different determinants of health would require cooperation with medical experts in different fields, epidemiologists and sociologists, among others. The Stockholm conference began with an attempt to assess the impact of health economics on policy and practice but this did not result in any clear agreement. It was recognized that economists had made a large contribution in supplying concepts and principles for debates on health care reform in a number of countries. For instance, Alain Enthoven and the Jackson Hole group in the USA have been quite influential in attempts to reform the US health care system, and the former also provided the initial ideas for reform in the UK, Russia, Israel and the Netherlands. These countries are in different phases of developing systems of managed competition, a process which requires solving a number of practical problems. This can be done by developing an adequate capitation formula for payments to insurers reflecting risk profiles of the insured population and/or a system of mandatory pooling among insurers of highrisk people. Several economists are working on these issues (Arlene Ash, Trevor Sheldon, Wynand Van de Ven and Rene Van Vliet) and their work will be of relevance to future health policy in these countries.
Probably the largest impact of health economics on health policy and practice comes from the increasing volume of economic appraisals as was apparent at the London conference. Cost-effectiveness information supports decision-making at various levels in the health care system. In some countries (e.g. the Netherlands), such information is systematically considered when major additions to the health insurance package (such as transplant programmes) are considered. The role of economic appraisal is also becoming more prominent in the pricing and reimbursement of pharmaceuticals. Australia is in the forefront and has had a system in place sinceJanuary 1993, in which pharmaceutical companies are required to submit the results of economic evaluation when they want their products included in the Pharmaceutical Benefits Scheme. In many other countries, economic appraisals are increasingly being used to support national policies on the reimbursement of pharmaceuticals. But to be fair, the impact of cost-effectiveness information is still rather limited when government policy at the national level is considered. In contrast, the gradual incorporation of economic considerations in clinical protocols and drug formularies is much more important and reflected in the increasing attention devoted to costeffectiveness in medical journals and, indeed, in the presentations at the London conference.
A number of speakers in London emphasized the need to understand the political and organisational processes that affect the acceptance of study results and their implementation in policy. As David Mechanic pointed out in the first issue of this journal, the failure of health care reform in the USA reflected aspects of that country's political culture and the power of interest groups. John Gabbay, Steve George, Rebecca Rosen and others also suggested that the dissemination and consequent implementation of research results in general and of cost-effectiveness studies in particular depend on the interests of professionals and the views of the public as well as the beliefs and personalities of key policy makers.
Louise Gunning-Schepers suggested that research should be better tailored to the needs of policy makers and illustrated this with the ability of models to demonstrate the impact of preventive programmes, taking into account the real dynamics of populations. This could facilitate the translation of results into policy. David Evans backed this up by suggesting that there is an urgent need for better knowledge of the factors that determinate the effectiveness of different national and local strategies for dissemination of research results relevant to policy and management.
Although we observe a fair amount of implementation of economic research results at the institutional level, this could be enhanced by devising appropriate incentives for the key actors. Such incentives should encourage them to act efficiently from a societal perspective. In reality, existing reimbursement systems in many health care systems do just the opposite. Apparent Scientific bases of health services obstacles are the compartmentalization of health care budgets which induce myopic behaviour by decision makers and traditional systems of remunerating doctors which keep them from investing in the development and use of research-based protocols and guidelines. Both the incorporation of the right incentives in our health care systems, which is a focus of interest of health economists, and the further education of decision makers in the principles of the discipline may help to bridge the gap between health economics research and health care policy and practice.
Frans Rutten PhD

Professor of Health Economics and Medical Technology Assessment
Erasmus University Rotterdam The Netherlands
Scientific bases versus scientism in health services
The strong conviction that scientific evidence and methods should be the cornerstone of Western medical decision-making is hardly new. Even if its history is limited to the 20th century, a more solid scientific basis for medicine was the driving force behind the Flexner Report in the late 1910s, resulting in the closing of 'unscientific' medical schools in the USA and a strengthening of its remaining training centres. The USA was hardly alone in this conviction. Indeed, the models in the report were based upon scientific medicine as already being practised in Europe. So why the apparent renewed attention to this topic?
The importance of a scientific basis in health services rests largely on the premise that better decisions about a patient's problems and their effective resolution could be made if only we could rid ourselves of the enemyuncertainties both about disease and about the best treatment strategy. Rationality in medical decisions has always conveyed special importance because patients' lives are at stake. Now, more than ever, the ability of health services to consume vast resources raises the pursuit of certainty to a new plateau of importance. Two areas of research demonstrate the extent of uncertainty in medical decision-making: the evidence that doctors vary widely in their treatment choices, variations which are not explained by disease or social factors; and the dearth of information about whether patients are truly better off after treatment or diagnostic testing. The great need for information and for new techniques of obtaining it occur at a time when computers have enhanced our ability to trace large numbers of patients across a spectrum of health service experiences and analyze large databases with new models and methods.
The need for such information is enhanced further by the continuing rise in the costs of health services and as technological advances sometimes outstrip our capacity to make wise or useful decisions about their application. The need to incorporate costs and to make choices among costly and uncertain alternatives has also led to a greater recognition of the role that patients' preferences should play, particularly where there is no right answer. It is not enough to incorporate patients' values into decisions as a part of the 'art' of medicinepatient preferences demand more scientific understanding before they can help inform medical decision-making.
Concurrently with genuine advances in scientificallybased diagnostic and treatment alternatives, scientism rears its head and invites practitioners to place undue faith in objective, 'scientific' measures. For example, in benign prostatic hyperplasia where the primary goal of treatment is symptom relief, the decision to operate often rests more heavily on objective measures such as urine flow rather than on subjective assessments ofsymptoms and their importance to the patient's quality of life. Scientism can also foster the temptation to conquer uncertainty by administering yet another diagnostic test, even if the treatment decision is unaffected. Last, scientism can lead to an over-reliance among researchers on the importance of classic experimental designs to discover evidence of effective methods for delivering health services.
Researchers and practitioners are not alone in confusing the importance of a scientific basis for health services with scientism. Managers, policy makers and students of the delivery of health services can also be guilty of over-extending their enthusiasm for a scientific basis of management, mistaking the existence of scientific techniques in management as proof that these strategies must lead to better outcomes for patients or more cost-effective delivery of services.
The recent international conference in London served to illustrate these two faces of scientific bases in management. The rhetoric emphasized the scientific bases inherent in quality improvement techniques to rationalize the production of care. This theme also echoes a wisdom heard before. Proponents of scientific
